16-Apr-2015, non health professional reported the case of a Female patient (age 60, 140lbs) who received ERYTHROMYCIN (Product be excluded as a Teva product). While on the suspect medication(s), the patient experienced ARRHYTHMIA(Serious); POSSIBLE DRUG INTERACTION(Serious).

The patient had medical history of CROHN'S DISEASE(Not Continuing), GASTROPARESIS(Not Continuing).
     
The patient's concomitant medication included  MESALAZINE( Unknown,  Dosage Form: Unspecified,  for CROHN'S DISEASE). 
The patient's past medication were unspecified.  

Lab tests were not reported.

This case was considered serious based on the following criteria: (Other Serious (Important Medical Events))

